Integral Diagnostics LimitedASX: IDXStrong FY26 outlook is offset by stretched momentum and resistance-driven correction risk.Stock Performance Profile: (Source: TradingView) 3-Month Performance Profile of IDX on a DTF compared to S&P/ASX 200 (XJO). Integral Diagnostics is expecting a strong FY26 result, with revenue forecast at $788–$790 million, around 25% higher year-on-year, wh
🔒
Subscribers only
Sign in with your subscriber account or subscribe to access this research report.
Required subscription
Daily Digest
A$200.00
Already a subscriber?
Sign in to read this report.
Required subscription
Daily Digest
Stay informed with expert daily ASX research covering four carefully selected stocks, complete with market insights, risk ratings, and clear Buy, Hold, or Sell general guidance—delivered before the market opens each trading day.
- ✓ Four Expert-Selected ASX Stocks Daily
- ✓ Weekday Pre-Market Delivery
- ✓ In-Depth Research & Analysis
- ✓ Access to All Previous Reports
A$200.00/ 12 months
Risk:Medium
Subscribe Now →
